Please assess the completion status of the following clinical trial:

Trial Title: Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent obtained prior to any protocol-specific procedures~* Male and female patients with histologically confirmed squamous cell carcinoma~* At least one site of active malignancy, as demonstrated on the pre-study 18F FDG PET/CT scan performed as part of routine clinical care~* Age \>/= 18 years~* Life expectancy \>/= 3 months~* ECOG Performance score of 0-2~Exclusion Criteria:~* Pregnant or breastfeeding females~* Systemic anti-neoplastic therapy within the 2 weeks prior to the pre-study 18F FDG PET/CT scan until after the 18F FPM PET/CT scan~* Any serious medical condition which the investigator feels may interfere with the procedures or evaluations of the study~* Patients unwilling or unable to comply with protocol or with a history of non-compliance or inability to grant informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- D-18F FPM (Type: EXPERIMENTAL): None
- L-18F FPM (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).